why choose us

First received: January 17, 2023

Clinical Trial: Drug Screening Using Novel IMD in Renal Cell Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Renal Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Pilot Study of an Implantable Microdevice for in Situ Evaluation of Drug Response in Renal Cell Carcinoma

Brief Summary: This research is being done to study the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of 19 specific drugs or drug combinations as a possible tool to evaluate the effectiveness of several cancer drugs against metastatic renal cell carcinoma (RCC).The name of the intervention(s) involved in this study are:Implantable Microdevice (IMD)Surgery (excision of tumor)Drugs used in this study will only include drugs already used as standard of care for the treatment of…

Read more